New ESMO data from three trial-sized cohorts, and a 25-month analysis of GitLab co-founder Sid Sijbrandij’s osteosarcoma highlight the potential to extract meaningful insights from limited patient data Madrid, Spain - October 23, 2026, BusinessWire Genialis, the therapeutic intelligence company, will present data at the European Society for Medical Oncology (ESMO) Congress 2026 showing […] The post From Small Clinical Trials to a Single Patient, Genialis Demonstrates the Power of Biology-First AI in Cancer Research appeared first on Genialis .